On this one, I feel that the cost of pharmaceutical drugs and the changes to the Patent Act, the scope of it inside the implementing legislation.... It's very serious. I cannot get a response from the minister or the government on this, any acknowledgement, I believe, of the fact that it will cost Canadians more money. I know we've heard that eight to 10 years is when we'll start to see the effects of that, but that's certainly not a long period of time before Canadians will start to pay more for their pharmaceutical drugs.
I think it is really incumbent on us to have a report containing an analysis of the potential impact of the agreement on the cost of pharmaceutical drugs in Canada. I don't believe it would be difficult to get, because the PBO received one from Health Canada. They put out to several departments around CETA a request for these reports, and Health Canada returned one. It's confidential, so we're unable to see that publicly, but data does exist on what the cost impact will be to Canadians. I think it's fair to ask that this data be revealed to Canadians so that they understand what we're facing in the patent changes that exist in CETA.
Is that possible? Do you have the Health Canada study that the PBO requested?